1192056-62-4

Basic information

• Product Name: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole
• Synonyms: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole;2-Methyl-oxazole-5-boronic acid pinacol ester
• CAS NO: 1192056-62-4
• Molecular Formula: C10H16BNO3
• Molecular Weight: 209.04994
• Mol File: 1192056-62-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 285.4±13.0 °C(Predicted)
• Appearance: /
• Density: 1.06±0.1 g/cm3(Predicted)
• PKA: 1.73±0.10(Predicted)
• CAS DataBase Reference: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole(1192056-62-4)
• EPA Substance Registry System: 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole(1192056-62-4)

Safety Data

• Hazardous Substances Data: 1192056-62-4(Hazardous Substances Data)

Usage

Description

2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole is an organic compound characterized by its unique molecular structure, which features a 2-methyl-oxazole core with a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group attached at the 5-position. 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole is known for its potential applications in the synthesis of various pharmaceuticals and chemical compounds.

Uses

Used in Pharmaceutical Synthesis:
2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole is used as an intermediate compound for the preparation of difluoromethyl-phenyl triazole derivatives. These derivatives are known to act as modulators of the GABA (gamma-aminobutyric acid) receptor, which plays a crucial role in the central nervous system. Modulating GABA receptors can have therapeutic applications in treating conditions such as anxiety, epilepsy, and other neurological disorders.
In the context of pharmaceutical research and development, 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Oxazole serves as a valuable building block for creating novel GABA receptor modulators with potential therapeutic benefits. Its unique structure allows for further functionalization and optimization to develop more effective and selective compounds for various medical applications.